New Update: Rising Oil Costs are Affecting Retirement Plans. Will you be impacted?
Barron’s: Awarded on 9/12/2025 (Mega RIA) for 6/30/24-6/30/25. Paid for logo use. Forbes: Awarded 10/1/25 for 3/31/24-3/31/25. Paid for logo use. USA Today: Awarded 4/15/26 for the five-year period ending January 2026. Paid for logo use.
Company:
Merck
Plan Administrator:
2000 galloping hill road
Kenilworth, NJ
7033
908-423-1000
Equity compensation can include restricted stock units (RSUs), stock options, performance shares, and employee stock purchase plan (ESPP) shares, and each vests and is taxed on its own schedule; the Merck section below shows which of these appear in Merck's own filings.
A restricted stock unit (RSU) is not stock itself. It is an unfunded promise to deliver shares, or sometimes cash, once a time-based or performance-based vesting condition is met; a performance share is simply an RSU with a performance-based condition.
Stock options give the right to buy shares at a fixed strike price. Nonqualified stock options (NSOs) can go to employees, consultants, or outside directors. Incentive stock options (ISOs) carry extra tax rules and may only go to employees of the company or a parent or subsidiary.
An ESPP lets employees buy company stock through payroll deductions, usually at a discount from the market price, and a plan that qualifies under Internal Revenue Code Section 423 carries its own holding-period rules for favorable tax treatment.
The plan document and the individual award agreement, not a general rule, control what happens to unvested RSUs, options, and performance shares when someone leaves Merck. Most plans stop vesting on the termination date and forfeit the unvested portion, though severance or retirement provisions in a specific plan can change that outcome.
To keep ISO tax treatment, the option generally must be exercised within 3 months after employment ends. If the employee left because of a permanent and total disability under Internal Revenue Code Section 22(e)(3), that window becomes 1 year instead, and an ISO exercised later is taxed going forward as a nonstatutory option.
RSUs are taxed as wages, not capital gains, at the point they vest and settle: the fair market value of the shares delivered, or the cash paid, that day goes into gross income and is reported on Form W-2.
Employers typically withhold federal income tax on RSU and NSO exercise income using the supplemental-wage rules: for 2026 the flat rate is 22% on up to $1 million of cumulative supplemental wages from one employer in the calendar year, and 37% on the excess.
An NSO is taxed at exercise, not at grant: the spread (the stock's fair market value minus the exercise price paid) counts as wages in the year of exercise.
Exercising an ISO creates no regular income tax, unlike an NSO exercise, but the spread is added back as an alternative minimum tax (AMT) adjustment on Form 6251, line 2i, so the exercise can still trigger AMT with no regular tax due.
For 2026, the AMT exemption is $90,100 for single filers and $140,200 for married couples filing jointly, phasing out once AMT income passes $500,000 (single) or $1,000,000 (joint). A 2025 law, the One, Big, Beautiful Bill Act, made those higher 2026 amounts permanent.
Selling ISO shares more than 2 years after the grant date and more than 1 year after the exercise date, a qualifying disposition, means the gain is taxed at long-term capital gains rates. Selling sooner, a disqualifying disposition, generally shifts part or all of that gain into ordinary wage income instead.
If the value of ISO shares that first become exercisable for one employee in a calendar year, across all of Merck's plans, tops $100,000 measured at grant, the excess loses ISO status and is taxed going forward as a nonstatutory option.
A Section 83(b) election applies to actual restricted stock, shares already transferred but still subject to forfeiture, not to RSUs, since an RSU holder has not yet received any property to elect on. Filing it lets an employee include the stock's value in income at grant instead of at vesting.
The IRS uses a standardized form for this, Form 15620, filable online or by mail, and the deadline is strict: no later than 30 days after the stock transfers, with no exceptions.
A Section 423 ESPP can price shares at up to a 15% discount, the lesser of 85% of fair market value at the start of the offering period or 85% of its value on the purchase date. The tax code also caps how much stock one employee can accrue the right to buy: no more than $25,000 of fair market value, measured at grant, for each calendar year the option is outstanding.
Selling the shares more than 2 years after the offering date and more than 1 year after the purchase date is a qualifying disposition: part of the gain, limited to the original discount, counts as ordinary income, and the rest is long-term capital gain. Selling sooner moves more of the gain into ordinary income.
Once RSU shares, exercised option shares, or ESPP shares are sold, any gain above the taxable basis is a capital gain, and the rate depends on how long the shares were held and on taxable income. For 2026, the 0% long-term capital gains rate applies up to taxable income of $49,450 (single) or $98,900 (married filing jointly). The 15% rate applies above that up to $545,500 (single) or $613,700 (joint), and amounts above those upper figures are taxed at 20%.
Higher earners may also owe the 3.8% net investment income tax on some of that gain. It applies to the lesser of net investment income or the amount modified adjusted gross income exceeds $200,000 (single) or $250,000 (married filing jointly), thresholds Congress set in 2013 and has not adjusted for inflation since.
Directors, officers, and other insiders who want to sell shares on a set schedule often use a Rule 10b5-1 trading plan. Under the SEC's 2022 amendments, a director or officer cannot start trading under a new or modified plan until a cooling-off period passes. That period is the later of 90 days after adoption or 2 business days after the next quarterly results are disclosed, capped at 120 days; other persons get a shorter 30-day period instead.
Everyone adopting a plan has to act in good faith, and directors and officers must certify at adoption that they are not aware of material nonpublic information. The rule also limits a person to one single-trade plan per 12-month period and restricts overlapping plans.
Separately, Merck has to state in its Form 10-K whether it has adopted insider trading policies for its directors, officers, and employees, and file those policies as an exhibit. Those filed policies are generally where blackout-window rules live, often tied to earnings announcements, when insiders cannot trade Merck stock.
Putting a large portion of personal wealth into one employer's stock concentrates risk, since a decline in that one company can affect a paycheck, unvested equity, and an investment account at the same time. The following is a short, clearly labeled hypothetical, not a projection of Merck stock or any real account.
For example, an employee might start with $100,000 in cash savings and $100,000 in vested company stock, half the $200,000 total in one stock. Over several years, that employee could sell newly vested shares as they vest and move the proceeds into other investments, gradually lowering how concentrated that stock position is. There is no fixed share that works for every situation, and this hypothetical does not say how any investment will perform.
Cash from selling vested RSU shares, exercised options, or ESPP shares can go toward ordinary savings and retirement accounts that each carry their own 2026 limit. For a 401(k), 403(b), or governmental 457(b) plan, the 2026 employee deferral limit is $24,500, with an extra $8,000 catch-up for employees 50 and older, or $11,250 instead for those turning 60 through 63 in 2026.
An IRA has a separate 2026 limit of $7,500, plus a $1,100 catch-up for those 50 and older. An employee enrolled in an HSA-eligible health plan can direct proceeds there too: the 2026 HSA contribution limit is $4,400 for self-only coverage and $8,750 for family coverage.
Knowing which award type you hold matters before any of the tax rules above come into play. Merck grants stock options to employees and directors at fair market value, generally vesting one-third a year over three years with a 7-to-10-year term, alongside RSUs on that same three-year schedule and performance share units that vest after a three-year performance period tied to pre-set goals. At the end of 2025, Merck reported 12.477 million options outstanding, 15.722 million nonvested RSUs and 1.834 million nonvested performance share units, with 66 million shares still authorized for future grants. Your own grant notice will show which of these award types and vesting dates apply to you.
Merck's own RSU award terms spell out a default rule and several carve-outs for employment changes. Leaving for most other reasons during the three-year restricted period forfeits the unvested RSUs on that date, but an involuntary termination after the first year, or a qualifying retirement (age 55 with 10 years of service, the age and service combination tied to subsidized retiree medical coverage, or age 65 regardless of service), instead vests a pro-rata share based on completed months out of 36. Death vests the award in full immediately, and disability keeps it vesting on the original schedule. Review your own separation paperwork against these terms before assuming either outcome.
How does Merck's new retirement benefits program support long-term financial security for employees, particularly regarding the changes to the pension and savings plans introduced in 2013? Can you elaborate on how Merck's commitment to these plans is designed to help employees plan for retirement effectively?
Merck's New Retirement Benefits Program: Starting in 2013, Merck introduced a comprehensive retirement benefits program aimed at providing all eligible employees, irrespective of their legacy company, uniform benefits. This initiative supports Merck's commitment to financial security by integrating pension plans, savings plans, and retiree medical coverage. This approach not only aims to help employees plan effectively for retirement but also aligns with Merck’s post-merger goal of standardizing benefits across the board.
What are the key differences between the legacy pension benefits offered by Merck before 2013 and the new cash balance formula implemented in the current retirement program? In what ways do these changes reflect Merck's broader goal of harmonizing benefits across various employee groups?
Differences in Pension Formulas: Before 2013, Merck calculated pensions using a final average pay formula which typically favored longer-term, older employees. The new scheme introduced a cash balance formula, reflecting a shift towards a more uniform accumulation of retirement benefits throughout an employee's career. This change was part of Merck's broader strategy to harmonize benefits across various employee groups, making it easier for employees to understand and track their pension growth.
In terms of eligibility, how have Merck's pension and savings plans adjusted for years of service and age of retirement since the introduction of the new program? Can you explain how these adjustments might affect employees nearing retirement age compared to newer employees at Merck?
Adjustments in Eligibility: The new retirement program revised eligibility criteria for pension and savings plans to accommodate a wider range of employees. Notably, the pension benefits under the new program are designed to be at least equal to the prior benefits for services rendered until the end of 2019, provided employees contribute a minimum of 6% to the savings plan. This adjustment aids both long-term employees and those newer to the company by offering equitable benefits.
Can you describe the transition provisions that apply to legacy Merck employees hired before January 1, 2013? How does Merck plan to ensure that these provisions protect employees from potential reductions in retirement benefits during the transition period?
Transition Provisions for Legacy Employees: For employees who were part of legacy Merck plans before January 1, 2013, Merck established transition provisions that allow them to earn retirement income benefits at least equal to their current pension and savings plan benefits through December 31, 2019. This ensures that these employees do not suffer a reduction in benefits during the transition period, offering a sense of security as they adapt to the new program.
How does employee contribution to the retirement savings plan affect the overall retirement benefits that Merck provides? Can you discuss the implications of Merck's matching contributions for employees who maximize their savings under the new retirement benefits structure?
Impact of Employee Contribution to Retirement Savings: In the new program, Merck encourages personal contributions to the retirement savings plan by matching up to 6% of employee contributions. This mutual contribution strategy enhances the overall retirement benefits, incentivizing employees to maximize their savings for a more robust financial future post-retirement.
What role does Merck's Financial Planning Benefit, offered through Ernst & Young, play in assisting employees with their retirement planning? Can you highlight how engaging with this benefit changes the financial landscapes for employees approaching retirement?
Role of Merck’s Financial Planning Benefit: Offered through Ernst & Young, this benefit plays a critical role in assisting Merck employees with retirement planning. It provides personalized financial planning services, helping employees understand and optimize their benefits under the new retirement framework. Engaging with this service can significantly alter an employee’s financial landscape by providing expert guidance tailored to individual retirement goals.
How should employees evaluate their options for retiree medical coverage under the new program compared to previous offerings? What considerations should be taken into account regarding the potential costs and benefits of the retiree medical plan provided by Merck?
Options for Retiree Medical Coverage: With the new program, employees must evaluate both subsidized and unsubsidized retiree medical coverage options based on their age, service length, and retirement needs. The program offers different levels of company support depending on these factors, making it crucial for employees to understand the potential costs and benefits to choose the best option for their circumstances.
In what ways does the introduction of voluntary, unsubsidized dental coverage through MetLife modify the previous dental benefits structure for Merck retirees? Can you detail how these changes promote cost efficiency while still providing valuable options for employees?
Introduction of Voluntary Dental Coverage: Starting January 2013, Merck shifted from sponsored to voluntary, unsubsidized dental coverage through MetLife for retirees. This change aligns with Merck’s strategy to promote cost efficiency while still providing valuable dental care options, allowing retirees to choose plans that best meet their needs without company subsidy.
How can employees actively engage with Merck's resources to maximize their retirement benefits? What specific tools or platforms are recommended for employees to track their savings and retirement progress effectively within the new benefits framework?
Engaging with Merck’s Retirement Resources: Merck provides various tools and platforms for employees to effectively manage and track their retirement savings and benefits. Employees are encouraged to utilize resources like the Merck Financial Planning Benefit and online benefit portals to make informed decisions and maximize their retirement outcomes.
For employees seeking additional information about the retirement benefits program, what are the best ways to contact Merck? Can you provide details on whom to reach out to, including any relevant phone numbers or online resources offered by Merck for inquiries related to the retirement plans?
Contacting Merck for Retirement Plan Information: Employees seeking more information about their retirement benefits can contact Merck through dedicated phone lines provided in the benefits documentation or by accessing detailed plan information online through Merck's official benefits portal. This ensures employees have ready access to assistance and comprehensive details regarding their retirement planning options.
For more information you can reach the plan administrator for Merck at 2000 galloping hill road Kenilworth, NJ 7033; or by calling them at 908-423-1000.
https://www.benefitsatmerck.com/wp-content/uploads/2023/09/MRK-2024-AE-mailer-L6a-092023-front-post-ltr.pdf - Page 5 https://www.horizonblue.com/merck/securecms-documents/2087/horizon-bcbs-merck-spd-2023-mpe.pdf - Page 12 https://www.merck.com/content/dam/merck/investors/financials/2023-annual-report.pdf - Page 15 https://www.merck.com/content/dam/merck/investors/financials/2024-annual-report.pdf - Page 8 https://www.horizonblue.com/merck/securecms-documents/2509/2024-merck-flexible-spending-accounts-summary-plan-description.pdf - Page 22 https://www.horizonblue.com/merck/securecms-documents/2023/horizon-bcbs-merck-2023.pdf - Page 28 https://www.benefitsatmerck.com/wp-content/uploads/2023/03/MRK-2023-AE-mailer-L6a-032023-front-post-ltr.pdf - Page 20 https://www.merck.com/content/dam/merck/investors/financials/2022-annual-report.pdf - Page 14 https://www.merck.com/content/dam/merck/investors/financials/2023-annual-funding-notice.pdf - Page 17 https://www.merck.com/content/dam/merck/investors/financials/2024-annual-funding-notice.pdf - Page 23
Choose the topics you’d love to read more about. Your input helps us focus on content that matters to you.